NCT02369835View on ClinicalTrials.gov

Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 18, 2018

Study Completion Date

July 18, 2018

Conditions

Head and Neck CarcinomaRadiation-Induced Dermatitis

Interventions

DRUG

Dakin's solution

Apply modified Dakin's solution (0.005 to 0.01%) topically

OTHER

Placebo

Applied topically

Trial Locations (2)

94305

Stanford University School of Medicine, Stanford

95124

Stanford Cancer Center South Bay, San Jose

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT02369835 - Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | Biotech Hunter | Biotech Hunter